Definitive Contract HDTRA117C0030
Award Date 6/22/17
Potential Completion Date 3/3/21
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
STTR Phase II
Primary Consortia Member
Not listed Similar Awards
- This is a $149,543.35 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Biological Mimetics, Inc., a small business, under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I SBIR project to develop a CRISPR-based diagnostic test for parasites. The contract has a period of performance through August 30, 2016. Biological Mimetics is a biotechnology firm that provides research, development, and testing services related to infectious...
- This is a Phase II SBIR contract award to Biological Mimetics, Inc., a biotechnology firm in Frederick, Maryland, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $1,498,641 Firm Fixed Price contract is for the development of a CRISPR-based diagnostic test for parasites, with a completion date of September 14, 2028. The contract is set aside for small businesses under the SBIR program, which aims to stimulate technological innovation. Biological...
- This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
- This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
- This is a $5,057,523.60 definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to Microbiotix, Inc., a clinical-stage biopharmaceutical company. The contract, which is not set-aside, supports the development of novel small molecule anti-infective drugs, with a focus on addressing unmet medical needs in infectious diseases. Microbiotix has received numerous federal contract and grant awards from agencies such as the National Institutes of Health (NIH) and the Department of...
- This $297,740 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CFD Research Corporation, a small business in Huntsville, Alabama. The contract is for the "Development of Bacteriophage for Treatment of Mycobacterial Infections", under SBIR Topic 131 from the SBIR/STTR solicitation PHS-2023-1. CFD Research specializes in engineering...
- This is a $299,959 SBIR Phase I contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company that develops drugs and vaccines for cancer, infectious diseases, and other unmet medical needs. The contract is for research, development, testing, and manufacturing services related to HDT Bio Corp's RNA technologies, adjuvants, antibodies, nanoparticles, and other platforms to create new medical...
- This is a Definitive Contract award under the Small Business Innovation Research (SBIR) program, issued by the U.S. Army's Medical Command (MEDCOM) to CFD Research Corporation, a small business based in Huntsville, Alabama. The $1,499,996.35 contract is for a Sequential Phase II effort titled "Producing Biosynthetic Therapeutics from Extreme Microbiomes" to develop medical R&D related to COVID-19. This award is set aside for small businesses. CFD Research has a history of receiving...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
- This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...